Back

Role of subclinical primary hyperaldosteronism on heart remodelling assessed by echocardiography: a population-based cohort study

30 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Antonio Angelico-Goncalves

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

3 More presentations in this session

Presentation thumbnail
Predicting postoperative myocardial infarction in noncardiac surgery patients using explainable artificial intelligence
Mr B. Arends (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Ceramides surpass LDL-cholesterol in predicting cardiovascular mortality in patients with as well as in patients without the metabolic syndrome
Doctor A. Mader (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Associations between an insulin resistance guide, the triglyceride glucose index (TyG) and subclinical atherosclerosis progression in a coronary population
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults
thumbnail
Congress Presentation
Autonomous cortisol secretion in patients with primary aldosteronism is associated with left ventricular hypertrophy and diastolic dysfunction
thumbnail
Congress Session
Hypertension in special circumstances

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources